Cormorant Asset Management as of March 31, 2019
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 64 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Inflarx Nv (IFRX) | 6.6 | $98M | 2.6M | 37.79 | |
| SPDR S&P Biotech (XBI) | 5.7 | $84M | 925k | 90.54 | |
| Mirati Therapeutics | 5.3 | $79M | 1.1M | 73.30 | |
| Ascendis Pharma A S (ASND) | 4.8 | $71M | 600k | 117.70 | |
| Apellis Pharmaceuticals (APLS) | 4.7 | $70M | 3.6M | 19.50 | |
| Anaptysbio Inc Common (ANAB) | 4.5 | $67M | 920k | 73.05 | |
| Biohaven Pharmaceutical Holding | 3.8 | $57M | 1.1M | 51.47 | |
| Reata Pharmaceuticals Inc Cl A | 3.5 | $53M | 615k | 85.47 | |
| Principia Biopharma | 3.2 | $48M | 1.4M | 34.00 | |
| Quotient | 2.8 | $41M | 4.6M | 9.01 | |
| Tricida | 2.6 | $39M | 1.0M | 38.62 | |
| Blueprint Medicines (BPMC) | 2.4 | $36M | 450k | 80.05 | |
| Sarepta Therapeutics (SRPT) | 2.4 | $36M | 300k | 119.19 | |
| Chemocentryx | 2.4 | $35M | 2.5M | 13.89 | |
| Galapagos Nv- (GLPG) | 2.4 | $35M | 300k | 116.55 | |
| Argenx Se (ARGX) | 2.3 | $34M | 275k | 124.84 | |
| Crispr Therapeutics (CRSP) | 2.2 | $32M | 900k | 35.72 | |
| Myokardia | 2.1 | $31M | 600k | 51.99 | |
| Axonics Modulation Technolog (AXNX) | 2.1 | $31M | 1.3M | 23.95 | |
| Allakos (ALLK) | 2.0 | $30M | 750k | 40.50 | |
| Rocket Pharmaceuticals (RCKT) | 2.0 | $30M | 1.7M | 17.54 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 1.8 | $27M | 850k | 31.47 | |
| Zogenix | 1.7 | $25M | 450k | 55.01 | |
| Kura Oncology (KURA) | 1.6 | $23M | 1.4M | 16.59 | |
| Kezar Life Sciences (KZR) | 1.6 | $23M | 1.3M | 17.74 | |
| Atara Biotherapeutics | 1.5 | $22M | 550k | 39.75 | |
| Sage Therapeutics (SAGE) | 1.4 | $21M | 130k | 159.05 | |
| Y Mabs Therapeutics (YMAB) | 1.3 | $19M | 716k | 26.21 | |
| Constellation Pharmceticls I | 1.2 | $17M | 1.3M | 13.55 | |
| Nektar Therapeutics (NKTR) | 1.1 | $17M | 500k | 33.60 | |
| Twist Bioscience Corp (TWST) | 1.1 | $16M | 706k | 23.18 | |
| Myovant Sciences | 1.1 | $16M | 650k | 23.87 | |
| Inspire Med Sys (INSP) | 1.0 | $14M | 250k | 56.78 | |
| Gossamer Bio (GOSS) | 1.0 | $14M | 653k | 21.67 | |
| Precision Biosciences Ord | 0.9 | $14M | 780k | 17.95 | |
| Amarin Corporation (AMRN) | 0.8 | $13M | 600k | 20.76 | |
| Array BioPharma | 0.8 | $12M | 500k | 24.38 | |
| Eidos Therapeutics | 0.8 | $12M | 508k | 23.45 | |
| Rubius Therapeutics | 0.8 | $12M | 650k | 18.10 | |
| Orchard Therapeutics Plc ads | 0.8 | $12M | 650k | 17.89 | |
| Arena Pharmaceuticals | 0.8 | $11M | 250k | 44.83 | |
| Zai Lab (ZLAB) | 0.7 | $10M | 350k | 29.51 | |
| Ra Pharmaceuticals | 0.6 | $9.0M | 400k | 22.40 | |
| Genfit S A ads (GNFT) | 0.6 | $8.4M | 350k | 24.00 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $7.9M | 90k | 88.10 | |
| Phasebio Pharmaceuticals | 0.5 | $8.0M | 840k | 9.51 | |
| Avrobio Ord (AVRO) | 0.5 | $6.6M | 300k | 22.05 | |
| Harpoon Therapeutics | 0.4 | $6.4M | 674k | 9.47 | |
| Kiniksa Pharmaceuticals | 0.3 | $4.9M | 270k | 18.06 | |
| Minerva Neurosciences | 0.3 | $4.8M | 608k | 7.86 | |
| Translate Bio | 0.3 | $4.6M | 455k | 10.19 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $4.4M | 253k | 17.41 | |
| Audentes Therapeutics | 0.3 | $3.9M | 100k | 39.02 | |
| Heron Therapeutics (HRTX) | 0.2 | $3.7M | 150k | 24.44 | |
| Scholar Rock Hldg Corp (SRRK) | 0.2 | $3.4M | 179k | 18.79 | |
| Iterum Therapeutics | 0.2 | $3.2M | 398k | 8.03 | |
| Abeona Therapeutics | 0.2 | $2.9M | 400k | 7.36 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.2 | $3.0M | 200k | 15.14 | |
| Incyte Corporation (INCY) | 0.2 | $2.6M | 30k | 86.00 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.5M | 421k | 5.99 | |
| Solid Biosciences | 0.2 | $2.3M | 250k | 9.20 | |
| Acceleron Pharma | 0.1 | $1.9M | 40k | 46.58 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $150k | 417k | 0.36 | |
| Cellectar Biosciences Equity Warrants *w | 0.0 | $4.8k | 53k | 0.09 |
